Ildong Pharmaceutical Co., Ltd. (249420.KS) KSC

Currency In KRW

AD

Valuation

Market Cap1.16T
Enterprise Value1.24T
P/E Ratio8.65
PEG Ratio0
Price/Sales Ratio0.76
Price/Book Ratio1.16
Enterprise/Revenue0.93
Enterprise/EBITDA-56.26

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.08
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.21

Income Statement

Revenue566.93B
Revenue/Share28,870.86
Gross Profit214.76B
EBITDA39.9B
Net Income27.66B
Diluted EPS936.77

Balance Sheet

Total Cash59.07B
Total Cash/Share2,913.43
Total Debt133.65B
Total Debt/Equity0.54
Current Ratio0.99
Book Value Per Share11,835.1

Price History

52-Week Change-27.56
52-Week High45,050
52-Week Low11,250
Moving Average 50 Days17,217.6
Moving Average 200 Days27,950.65

Statistics

Average Volume178,824
Shares Outstanding31.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate200
Trailing Annual Dividend Yield1.41
Payout Ratio0
Last Split Factor21:20
Last Split DateMarch 05, 2020
AD